Nanexa: Evaluation Agreement Novo Nordisk - Redeye

Redeye is impressed and relieved by yesterday’s news that Nanexa has signed an exclusivity- and evaluation agreement with Novo Nordisk worth SEK46m. In connection with the agreement, a directed issue of SEK17m was also conducted to Novo Nordisk. We give our initial take.

Länk till analysen i sin helhet: https://www.redeye.se/research/869636/nanexa-evaluation-agreement-novo-nordisk?utm_source=finwire&utm_medium=RSS